Search

Craig G Wilde

from Sunnyvale, CA
Age ~71
Get Report
Also known as:
Craig Gerard Wilde, Craig Te Wilde, Craig F Wilde, Craig G Wiloe
Phone and address:
1239 Mandarin Dr, Sunnyvale, CA 94087
(408) 245-6063
Related to:
Ryan Richard Kennedy, 56Phillip Rose, 69Norman Ross, 63Edward Mcadoo
Connected to:
Aaron M Wilde, 54Alfred F Wilde, 119Amie D Wilde, 40Ana M Wilde, 41Aubrey Wilde, 39Austin C Wilde, 64Bill T Wilde, 57Brendan P Wilde, 39Bruce A Wilde, 68Cameron D Wilde, 37

Craig Wilde Phones & Addresses

  • 1239 Mandarin Dr, Sunnyvale, CA 94087 (408) 245-6063
  • Mountain View, CA
  • Foster City, CA
  • 16342 Briarwood Ct, Olathe, KS 66062 (913) 782-2792
  • Shawnee Mission, KS
  • Chicago, IL
  • Lawrence, KS
  • Overland Park, KS
  • Santa Clara, CA

Resumes

Resumes

Craig Wilde Photo 1

Craig Wilde

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Genomic Health 2009 - 2010
Corporate Development Consultant
Genomic Health Sep 2006 - Jun 2009
Intellectual Property Manager
Delta Consulting Group 2002 - 2006
Independent Consultant
Incyte Jan 1996 - Apr 2001
Senior Director Business Development
Incyte Pharmaceuticals 1991 - Dec 1995
Research Group Leader
Education:
Harvard Medical School 1983 - 1987
The University of Kansas 1977 - 1983
Doctorates, Doctor of Philosophy, Biochemistry The University of Kansas 1972 - 1976
Bachelors, Bachelor of Science, Chemistry
Skills:
Biotechnology
Commercialization
Business Development
Lifesciences
Genomics
Intellectual Property
Oncology
Biopharmaceuticals
Pharmaceutical Industry
Licensing
Molecular Biology
Cancer
Drug Discovery
Immunology
Technology Transfer
Biochemistry
Craig Wilde Photo 2

Intellectual Property Manager

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
Genomic Health
Intellectual Property Manager
Craig Wilde Photo 3

Craig Wilde

View page
Craig Wilde Photo 4

Craig Wilde

View page
Skills:
Home Repair and Explosives

Publications

Us Patents

Antibodies To A Chemokine Expressed In Inflamed Adenoid

View page
US Patent:
6692920, Feb 17, 2004
Filed:
Jun 5, 2000
Appl. No.:
09/588044
Inventors:
Karl J. Guegler - Menlo Park CA
Phillip R. Hawkins - Mountain View CA
Craig G. Wilde - Sunnyvale CA
Jeffrey J. Seilhamer - Los Altos Hills CA
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
A61K 39395
US Classification:
435 71, 5303879, 5303881, 53038815, 53038823, 53038824, 5303892, 530413, 4241301, 4241391, 4241451, 514 2, 514 8, 514 12, 436547, 436548
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.

Chemokine Panec-1 Polynucleotides And Compositions And Methods Related Thereto

View page
US Patent:
7005509, Feb 28, 2006
Filed:
Feb 17, 1995
Appl. No.:
08/390740
Inventors:
Roger Coleman - Mountain View CA, US
Olga Bandman - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07H 21/00
C12Q 1/68
C12P 19/34
US Classification:
536 231, 536 221, 435 6, 435 912
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Chemokine Panec-2 Polypeptides And Compositions And Methods Related Thereto

View page
US Patent:
7396652, Jul 8, 2008
Filed:
Nov 27, 2006
Appl. No.:
11/604251
Inventors:
Roger T. Coleman - Seattle WA, US
Olga Bandman - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Assignee:
INCYTE Corporation - Wilmington DE
International Classification:
A61K 38/00
A61K 49/00
US Classification:
435 71, 435 694, 435 697, 436501, 4241981, 530350, 530399
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Methods Of Treatment With Anitbodies To A Chemokine Expressed In Inflamed Adenoid

View page
US Patent:
7708984, May 4, 2010
Filed:
Jun 4, 2007
Appl. No.:
11/806846
Inventors:
Karl J. Guegler - Menlo Park CA, US
Phillip R. Hawkins - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Jeffrey J. Seilhamer - Los Altos Hills CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 38/19
US Classification:
424 851, 514 2, 514885
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.

Chemokine Panec-1 Antibodies

View page
US Patent:
7803373, Sep 28, 2010
Filed:
May 20, 2008
Appl. No.:
12/153507
Inventors:
Roger T. Coleman - Seattle WA, US
Olga Bandman - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Assignee:
Incyte Pharmaceuticals, Inc. - Wilmington DE
International Classification:
A61K 39/00
A61K 39/395
C07K 16/24
C07K 16/00
US Classification:
4241391, 4241411, 4241451, 5303871, 5303891
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Methods Of Screening For Compounds That Modulate The Activity Of Adec, A Chemokine Expressed In Inflamed Adenoid

View page
US Patent:
8008027, Aug 30, 2011
Filed:
Mar 24, 2010
Appl. No.:
12/730953
Inventors:
Karl J. Guegler - Menlo Park CA, US
Phillip R. Hawkins - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Jeffrey J. Seilhamer - Los Altos Hills CA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
G01N 33/53
G01N 33/567
US Classification:
435 71, 435 72, 435 721, 435 724
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (ADEC) from inflamed adenoid tissue. The present invention also provides for antisense molecules to the nucleotide sequences which encode ADEC, expression vectors for the production of purified ADEC, antibodies capable of binding specifically to ADEC, hybridization probes or oligonucleotides for the detection of ADEC-encoding nucleotide sequences, genetically engineered host cells for the expression of ADEC, diagnostic tests for inflammation or disease based on ADEC-encoding nucleic acid molecules or antibodies capable of binding specifically to ADEC.

Methods Of Diagnosing Pancreatic Inflammation By Using Chemokine Panec-1 Antibodies

View page
US Patent:
8617551, Dec 31, 2013
Filed:
Aug 10, 2010
Appl. No.:
12/854005
Inventors:
Roger T. Coleman - Seattle WA, US
Olga Bandman - Mountain View CA, US
Craig G. Wilde - Sunnyvale CA, US
Assignee:
Incyte Corporation - Palo Alto CA
International Classification:
A61K 39/00
A61K 39/395
C07K 16/24
C07K 16/00
US Classification:
4241391, 4241411, 4241451, 5303871, 5303891
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode novel expressed chemokines (PANEC-1 and PANEC-2) from human pancreas cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode PANEC-1 and PANEC-2, expression vectors for the production of purified PANEC-1 and PANEC-2, antibodies capable of binding specifically to PANEC-1 and PANEC-2, hybridization probes or oligonucleotides for the detection of PANEC-1- or PANEC-2-encoding nucleotide sequences, genetically engineered host cells for the expression of PANEC-1 and PANEC-2, diagnostic tests for chemokine activation based on PANEC-1- and PANEC-2-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.

Chemokine Expressed In Fetal Spleen, Its Production And Uses

View page
US Patent:
20020142398, Oct 3, 2002
Filed:
May 29, 2002
Appl. No.:
10/158366
Inventors:
Roger Coleman - Mountain View CA, US
Craig Wilde - Sunnyvale CA, US
Jeffrey Seilhamer - Los Altos Hills CA, US
Assignee:
Incyte Genomics, Inc.
International Classification:
C07K014/52
A01K067/00
C07H021/04
C12P021/02
C12N005/08
C12N001/21
US Classification:
435/069500, 435/320100, 435/366000, 530/351000, 435/252300, 536/023500, 800/008000
Abstract:
The present invention provides nucleotide and amino acid sequences that identify and encode a novel expressed chemokine (FSEC) from human fetal spleen cells. The present invention also provides for antisense molecules to the nucleotide sequences which encode FSEC, expression vectors for the production of purified FSEC, antibodies capable of binding specifically to FSEC, hybridization probes or oligonucleotides for the detection of FSEC-encoding nucleotide sequences, genetically engineered host cells for the expression of FSEC, diagnostic tests for chemokine activation based on FSEC-encoding nucleic acid molecules and antibodies capable of binding specifically to the protein.
Control profile
Craig G Wilde from Sunnyvale, CA, age ~71 Get Report